RNA (5'-(*GP*GP*CP*AP*GP*AP*UP*CP*UP*GP*AP*GP *CP*CP*UP*GP*GP*GP*AP*GP*CP*UP*CP*UP*CP*UP*GP*CP*C) -3') / HIV-1 TAR RNA
分子量: 9307.555 Da / 分子数: 1 / 由来タイプ: 合成 詳細: 29 NUCLEOTIDE SEQUENCE COMPRISING PRIMARY BINDING SITE OF HIV-1 TAT, SYNTHESIZED USING T7 RNA POLYMERASE OFF OF A DNA TEMPLATE 由来: (合成) HUMAN IMMUNODEFICIENCY VIRUS 1 (CLONE 12) (ヒト免疫不全ウイルス)
Text: THE STRUCTURE WAS DETERMINED USING HOMONUCLEAR NMR SPECTROSCOPY, DETECTING INTERMOLECULAR NOES. RNA INTRAMOLECULAR RESTRAINTS WERE AS IN ABOUL-ELA ET AL, JMB 1995, AS THE NMR SPECTRA FOR THE ...Text: THE STRUCTURE WAS DETERMINED USING HOMONUCLEAR NMR SPECTROSCOPY, DETECTING INTERMOLECULAR NOES. RNA INTRAMOLECULAR RESTRAINTS WERE AS IN ABOUL-ELA ET AL, JMB 1995, AS THE NMR SPECTRA FOR THE RNA AS ABOUND BY THE LIGAND RBT203 SHOWED SIMILAR NOE AND CHEMICAL SHIFT PATTERNS TO THE LATTER
-
試料調製
試料状態
イオン強度: 20 mM / pH: 6.1 / 圧: 1 atm / 温度: 298 K
結晶化
*PLUS
手法: other / 詳細: NMR
-
NMR測定
NMRスペクトロメーター
タイプ
製造業者
モデル
磁場強度 (MHz)
Spectrometer-ID
Bruker DRX
Bruker
DRX
800
1
Bruker DRX
Bruker
DRX
600
2
Bruker DMX
Bruker
DMX
600
3
Bruker AMX
Bruker
AMX
500
4
-
解析
NMR software
名称
開発者
分類
X-PLOR
BRUNGER
精密化
XPLOR/CHARMM
構造決定
精密化
手法: NOE-RESTRAINED DYNAMICS / ソフトェア番号: 1 詳細: REFINEMENT INCLUDED A NUMBER OF MODELLING CONSTRAINTS BASED UPON PREVIOUSLY PUBLISHED DATA, AS WELL AS FINAL GENTLE REFINEMENT STEP USING CHARMM. DETAILS CAN BE FOUND IN THE JOURNAL CITATION ABOVE
NMRアンサンブル
コンフォーマー選択の基準: LEAST RESTRRAINT VIOLATION ENERGY 計算したコンフォーマーの数: 50 / 登録したコンフォーマーの数: 1